Anti-Vinculin antibody [EPR8185] - Loading Control
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(21 Reviews)
|
(523 Publications)
Anti-Vinculin antibody [EPR8185] (ab129002) is a rabbit monoclonal antibody detecting Vinculin in Western Blot, Flow Cytometry (Intra), IP, ICC/IF. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 350 publications
View Alternative Names
Vinculin, Metavinculin, MV, VCL
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Immunofluorescent staining of HEK293 cells (fixed in 4% PFA, permeabilized with 0.1% Triton X 100) using purified ab129002 at a dilution of 1/50. An Alexa Fluor® 488 goat anti-rabbit antibody (ab150077) was used as the secondary at a dilution of 1/1000 and the cells were counter stained with DAPI. The negative controls are shown in the bottom middle and right hand panels. For negative control 1, the primary was used and then goat anti-mouse IgG was used at a dilution of 1/500. For negative control 2, a mouse primary antibody (ab7291) and anti-rabbit secondary antibody (ab150077) were used.
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Western blot : Anti-VCL antibody [EPR8185] (ab129002) staining at 1/10000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab129002 was shown to bind specifically to VCL. A band was observed at 124 kDa in wild-type A431 cell lysates with no signal observed at this size in VCL knockout cell line. To generate this image, wild-type and VCL knockout A431 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (ab129002) at 1/10000 dilution
Lane 1:
Wild-type A431 cell lysate
Lane 2:
Western blot - Human VCL (Vinculin) knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-vcl-vinculin-knockout-a-431-cell-line-ab261898'>ab261898</a>) at 20 µg
Lane 2:
VCL knockout A431 cell lysate
Lane 3:
HeLa cell lysate
Lane 4:
Jurkat cell lysate
false
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Immunofluorescent staining of vinculin in HUVEC cells with unpurified ab129002 at 1/100 dilution.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Intracellular Flow Cytometry analysis of 293 (human embryonic kidney epithelial) cells labeling Vinculin (red) with ab129002 at a 1/200 dilution. Cells were fixed with 4% paraformaldehyde and permeabilized with 90% methanol. A goat anti-rabbit IgG (Alexa Fluorr® 488) (ab150077) was used as the secondary antibody at a 1/2000 dilution. Black - Rabbit monoclonal IgG (ab172730). Blue (unlabeled control) - Cells without incubation with the primary and secondary antibodies.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Flow cytometry overlay histogram showing wild-type A-431 (green line) and VCL knockout A-431 stained with ab129002 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab129002) (1x 106 in 100μl at 0.00032 μg/ml (1/6249999)) for 30min at 22°C.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C
Isotype control antibody Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control was used at the same concentration and conditions as the primary antibody (wild-type A-431 - black line, VCL knockout A-431 - grey line). Unlabelled sample was also used as a control (this line is not shown for the purpose of simplicity).
Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Flow cytometry overlay histogram showing left HeLa positive cells and right negative HeLa VCL KO stained with ab129002 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab129002) (1x 106 in 100μl at 0.008μg/ml (1/7875)) for 30min at 22°C.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C
Isotype control antibody (black line) was Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.
Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.
- IP
Lab
Immunoprecipitation - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
ab129002 (purified) at 1/20 immunoprecipitating vinculin in HeLa cells. Lane 1 : HeLa whole cell lysate (10 μg). Lane 2 : HeLa whole cell lysate (10 μg). Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab129002 in HeLa whole cell lysate. For western blotting, a HRP-conjugated goat anti-rabbit antibody was used as the secondary antibody (1/1000).
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Immunoprecipitation - Anti-Vinculin antibody [EPR8185] - Loading Control (ab129002)
Predicted band size: 124 kDa
false
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-Wnt11 antibody [EPR25633-141] (<a href='/en-us/products/primary-antibodies/wnt11-antibody-epr25633-141-ab316738'>ab316738</a>) at 1/1000 dilution
Lane 1:
Untreated JEG-3 (human placenta epithelial cell) whole cell lysate at 60 µg
Lane 2:
JEG-3 treated with 300 ng/ml Brefeldin A for 24h whole cell lysate at 60 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 39 kDa,124 kDa
false
Exposure time: 8s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Negative control : T-47D, MCF7.
Samples are non-boiled as boiling may cause protein aggregation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-PIEZO2 antibody [EPR27152-48] (<a href='/en-us/products/primary-antibodies/piezo2-antibody-epr27152-48-ab318187'>ab318187</a>) at 1/1000 dilution
Lane 1:
MKL-1 (human Skin Loosely packed floati aggregates with irregular outline and no central necrosis) whole cell lysate at 48 µg
Lane 2:
T-47D (human ductal breast epithelial tumor epithelial cell) whole cell lysate at 48 µg
Lane 3:
MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate at 48 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 320 kDa,124 kDa
false
Exposure time: 92s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Negative control : NCI-H1975 (PMID : 31231131), A549 (PMID : 31231131).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
Exposure time : Lane 1-2 : 3 seconds, Lane 3-4 : 26 seconds
All lanes:
Western blot - Anti-Wnt11 antibody [EPR25633-141] (<a href='/en-us/products/primary-antibodies/wnt11-antibody-epr25633-141-ab316738'>ab316738</a>) at 1/1000 dilution
Lane 1:
TF-1 (human Erythroleukemia erythroblast) whole cell lysate at 60 µg
Lane 2:
NCI-H1975 (human adenocarcinoma lung epithelial cell) whole cell lysate at 60 µg
Lane 3:
Saos-2 (human osteosarcoma epithelial cell) whole cell lysate at 60 µg
Lane 4:
A549 (human lung carcinoma epithelial cell) whole cell lysate at 60 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 39 kDa,36 kDa,124 kDa
false
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-CSB antibody [EPR27019-44] (<a href='/en-us/products/primary-antibodies/csb-antibody-epr27019-44-ab316744'>ab316744</a>) at 1/1000 dilution
Lane 1:
U-2OS (human bone osteosarcoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 200 kDa,124 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 22558357; PMID : 19166587).
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
The identity of the lower band at approximately 140 kDa is likely SET-NUP214 fusion protein.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
Exposure time : Lanes 1-2 : 180 seconds; Lanes 3 : 37 seconds
All lanes:
Western blot - Anti-NUP214 antibody [EPR29100-623] (<a href='/en-us/products/primary-antibodies/nup214-antibody-epr29100-623-ab325238'>ab325238</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 3:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 268 kDa,124 kDa
false
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Performed under reducing conditions.
In Western blot, ab325390 was shown to bind specifically to ATRX. Target of interest was observed at 310 kDa in wild-type A549 cell lysates (lane 1) with no signal observed at this size in ATRX knockout cell line (lane 2, knockout cell line ab287232).
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-ATRX antibody [EPR29209-280] (<a href='/en-us/products/primary-antibodies/atrx-antibody-epr29209-280-ab325390'>ab325390</a>) at 1/1000 dilution
Lane 1:
Wild-type A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
ATRX knockout A549 whole cell lysate
Lane 3:
Wild-type A549 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 310 kDa,124 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Negative control : adult skeletal muscle, adult lung (PMID : 25957469; PMID : 3530499).
Low expression : HEK-293 (PMID : 25957469)
The expression profile observed is consistent with what has been described in the literature (PMID : 3530499, PMID : 12899730, PMID : 31579487, PMID : 25957469 ).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
Exposure time : Lanes 1-4 : 59 seconds; Lanes 5-9 : 15 seconds
All lanes:
Western blot - Anti-heavy chain Myosin/MYH3 antibody [EPR29772-555] (<a href='/en-us/products/primary-antibodies/heavy-chain-myosin-myh3-antibody-epr29772-555-ab325795'>ab325795</a>) at 1/1000 dilution
Lane 1:
Untreated C2C12 (mouse myoblast) whole cell lysate at 20 µg
Lane 2:
C2C12 differentiation to muscle for 3 days whole cell lysate at 20 µg
Lane 3:
RD (human muscle multinucleated spindle-shaped cell) whole cell lysate at 20 µg
Lane 4:
HEK-293 (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 5:
Mouse E14 forelimb tissue lysate at 20 µg
Lane 6:
Mouse embryo tissue lysate at 20 µg
Lane 7:
Mouse E12.5 embryo tissue lysate at 20 µg
Lane 8:
Mouse adult skeletal muscle tissue lysate at 20 µg
Lane 9:
Mouse adult lung tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 223 kDa,124 kDa
false
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
The identity of the higher MW band at approximately 250 kDa is unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-LARP1 antibody [EPR28797-92] (<a href='/en-us/products/primary-antibodies/larp1-antibody-epr28797-92-ab317575'>ab317575</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 2:
HeLa transfected with siRNA specifically targeting LARP1 whole cell lysate at 20 µg
Lane 3:
PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
SW480 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
HEK293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 150 kDa,124 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Negative control : HEL
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-Agrin antibody [EPR28043-55] (<a href='/en-us/products/primary-antibodies/agrin-antibody-epr28043-55-ab316754'>ab316754</a>) at 1/1000 dilution
Lane 1:
HaCaT (human skin keratinocyte) whole cell lysate at 40 µg
Lane 2:
HEL (human Erythroleukemia erythroblast) whole cell lysate at 40 µg
Lane 3:
Huh7 (human hepatocellar carcinoma epithelial cell) whole cell lysate at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 260 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
This antibody was tested on fresh and frozen HeLa and 293T Whole Cell Lysate. The Lysates in lanes 3-4 were freshly made and used for Western Blotting immediately to minimize protein degradation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
Exposure time : Lane 1-2 : 103 seconds; Lane 3-4 : 180 seconds
All lanes:
Western blot - Anti-CSB antibody [EPR27019-44] (<a href='/en-us/products/primary-antibodies/csb-antibody-epr27019-44-ab316744'>ab316744</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 3:
HeLa whole cell lysate at 20 µg
Lane 4:
293T whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 200 kDa,124 kDa
false
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
The identity of the band at 100 kDa is unknown.
The bands beneath the target band between 100 kDa and 260 kDa (Lane 1-8) are likely to be degraded target fragments.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
Exposure time : Lane 1-8 : 15 seconds; Lane 9-12 : 48 seconds
All lanes:
Western blot - Anti-POLE antibody [EPR28639-64] (<a href='/en-us/products/primary-antibodies/pole-antibody-epr28639-64-ab318968'>ab318968</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 3:
MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
THP-1 (human monocytic leukemia monocyte) whole cell lysate at 20 µg
Lane 5:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 6:
F9 (mouse embryonal carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 7:
PC-12 (rat adrenal gland pheochromocytoma cell) whole cell lysate at 20 µg
Lane 8:
C6 (rat glial tumor glial cell) whole cell lysate at 20 µg
Lane 9:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell fresh lysate at 20 µg
Lane 10:
293T (human embryonic kidney epithelial cell) whole cell fresh lysate at 20 µg
Lane 11:
NIH/3T3 (mouse embryonic fibroblast) whole cell fresh lysate at 20 µg
Lane 12:
PC-12 (rat adrenal gland pheochromocytoma cell) whole cell fresh lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 260 kDa,124 kDa
false
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 22558357; PMID : 19166587).
To minimize protein degradation, cells were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
The identity of the lower band at approximately 140 kDa is likely a SET-NUP214 fusion protein.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) 1 : 10000 (124Kda).
All lanes:
Western blot - Anti-NUP214 antibody [EPR29100-623] (<a href='/en-us/products/primary-antibodies/nup214-antibody-epr29100-623-ab325238'>ab325238</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 48 µg
Lane 2:
HeLa transfected with siRNA specifically targeting NUP214 whole cell lysate at 48 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 268 kDa,124 kDa
false
Exposure time: 180s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
This blot was developed using a high-sensitivity ECL substrate, allowing for the detection of proteins in the mid-femtogram range.
To minimize protein degradation, the fresh lysates were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-ATR antibody [EPR30640-130] (<a href='/en-us/products/primary-antibodies/atr-antibody-epr30640-130-ab325605'>ab325605</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 2:
HeLa transfected with siRNA specifically targeting ATR whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 270 kDa,124 kDa
true
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
The identity of the band at 100 kDa is unknown.
The bands beneath the target band between 100 kDa and 260 kDa are likely to be degraded target fragments.
In Western blot, ab318968 was shown to bind specifically to POLE. Target of interest was observed at 260kDa in wild-type HAP1 cell lysates (Lane 1) with no signal observed at this size in POLE knockout cell line (Lane 2).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-POLE antibody [EPR28639-64] (<a href='/en-us/products/primary-antibodies/pole-antibody-epr28639-64-ab318968'>ab318968</a>) at 1/1000 dilution
Lane 1:
parental HAP1(HOWT01) (human chronic myelogenous leukemia near-haploid cell ) whole cell lysate at 20 µg
Lane 2:
POLE Knockout HAP1(HO010404) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 260 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Negative control : kidney
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
Exposure time : Lanes 1-2 : 10 seconds, Lanes 3-8 : 6 seconds
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-NEFH antibody [EPR20020] - Neuronal Marker - Chicken IgY (Chimeric) (<a href='/en-us/products/primary-antibodies/nefh-antibody-epr20020-neuronal-marker-chicken-igy-chimeric-ab317042'>ab317042</a>) at 1/1000 dilution
Lane 1:
Human Brainstem tissue lysate at 20 µg
Lane 2:
Human kidney tissue lysate at 20 µg
Lane 3:
Mouse cerebellum tissue lysate at 20 µg
Lane 4:
Mouse brain tissue lysate at 20 µg
Lane 5:
Mouse kidney tissue lysate at 20 µg
Lane 6:
Rat cerebellum tissue lysate at 20 µg
Lane 7:
Rat brain tissue lysate at 20 µg
Lane 8:
Rat kidney tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Chicken IgY H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-chicken-igy-h-l-hrp-ab6877'>ab6877</a>) at 1/100000 dilution
Observed band size: 200-210 kDa,124 kDa
false
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-UNG2 antibody [EPR29004-78] (<a href='/en-us/products/primary-antibodies/ung2-antibody-epr29004-78-ab318982'>ab318982</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 50 µg
Lane 2:
HeLa transfected with siRNA specifically targeting UNG2 whole cell lysate at 50 µg
Lane 3:
293T (human embryonic kidney epithelial cell) whole cell lysate at 50 µg
Lane 4:
Caco-2 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 50 µg
Lane 5:
T-47D (human ductal breast epithelial tumor epithelial cell) whole cell lysate at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 37 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
The expression profile/ molecular weight observed isconsistent with what has been described in the literature (PMID : 34736895).
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
The identity of the band below 100 kDa is unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-Rif1 antibody [EPR27131-83] (<a href='/en-us/products/primary-antibodies/rif1-antibody-epr27131-83-ab316748'>ab316748</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 40 µg
Lane 2:
HeLa transfected with siRNA specifically targeting Rif1 whole cell lysate at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 110-310 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression of CCL1 is upregulated in response to PMA, GM-CSF and BFA treatment.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-CCL1 antibody [EPR28766-53] (<a href='/en-us/products/primary-antibodies/ccl1-antibody-epr28766-53-ab317571'>ab317571</a>) at 1/1000 dilution
Lane 1:
U-937 (human histiocytic lymphoma monocyte) treated with 100nM PMA for 3 days whole cell lysate at 60 µg
Lane 2:
U-937 treated first with 100nM PMA for 3 days, then replaced with 50ng/ml GM-CSF for 24h, 5µg/ml BFA was then added for additional 4h at 60 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 15 kDa,124 kDa
false
Exposure time: 114s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Negative control : HeLa, Raji (PMID : 35839778), human skeletal muscle.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
Exposure time : Lanes 1-4, 6-7 : 10 seconds; Lanes 5 : 1 second;
All lanes:
Western blot - Anti-Lrp2 / Megalin antibody [RM1150] (<a href='/en-us/products/primary-antibodies/lrp2-megalin-antibody-rm1150-ab317333'>ab317333</a>) at 1/1000 dilution
Lane 1:
JEG-3 (human placenta epithelial cell) whole cell lysate at 40 µg
Lane 2:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 40 µg
Lane 3:
Raji (human Burkitts lymphoma B lymphocyte) whole cell lysate at 40 µg
Lane 4:
Caco-2 (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 40 µg
Lane 5:
Human kidney tissue lysate at 40 µg
Lane 6:
Human placenta tissue lysate at 40 µg
Lane 7:
Human skeletal muscle tissue lysate at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 522 kDa,124 kDa
false
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST. ab129002 was used as a loading control.
All lanes:
Western blot - Anti-Creatine Kinase MM antibody [3E5BA5] (<a href='/en-us/products/primary-antibodies/creatine-kinase-mm-antibody-3e5ba5-ab110319'>ab110319</a>) at 1/50 dilution
Lane 1:
Mouse skeletal muscle tissue lysate at 20 µg
Lane 2:
Mouse spleen tissue lysate at 20 µg
Lane 3:
Mouse placenta tissue lysate at 20 µg
Lane 4:
Human skeletal muscle tissue lysate at 20 µg
Lane 5:
Human spleen tissue lysate at 20 µg
Lane 6:
Human placenta tissue lysate at 20 µg
Predicted band size: 43 kDa
Observed band size: 43 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
The identity of the bands between 100 kDa and 130 kDa are unknown.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
In Western blot, Anti-ATR antibody - Total protein control staining at 1/1000 dilution.
All lanes:
Western blot - Anti-ATR (phospho S428) antibody [EPR25772-3F09] (<a href='/en-us/products/primary-antibodies/atr-phospho-s428-antibody-epr25772-3f09-ab316925'>ab316925</a>) at 1/1000 dilution
Lane 1:
Untreated HT-29 (human colorectal adenocarcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
HT-29 treated with 100mJ/cm2 UV, then recovery for 30 minutes, whole cell lysate (untreated membrane) at 20 µg
Lane 3:
HT-29 treated with 100mJ/cm2 UV, then recovery for 30 minutes, whole cell lysate (Lambda phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 290 kDa,124 kDa
true
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : PC-3
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-RASA2 antibody [EPR29503-39] (<a href='/en-us/products/primary-antibodies/rasa2-antibody-epr29503-39-ab323554'>ab323554</a>) at 1/1000 dilution
Lane 1:
DLD-1 (human colorectal adenocarcinoma epithelial cell) whole lysate at 20 µg
Lane 2:
PC-3 (human prostate adenocarcinoma epithelial cell) whole lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 96 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Negative control : HepG2, K-562
Samples are non-boiled as boiling may cause protein aggregation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-GPR177/WLS antibody [EPR29686-569] (<a href='/en-us/products/primary-antibodies/gpr177-wls-antibody-epr29686-569-ab323481'>ab323481</a>) at 1/1000 dilution
Lane 1:
HaCaT (human skin keratinocyte) whole lysate at 50 µg
Lane 2:
A-204 (human muscle rhabdomyosarcoma cell) whole lysate at 50 µg
Lane 3:
HepG2 (human hepatocellular carcinoma epithelial cell) whole lysate at 50 µg
Lane 4:
K-562 (human chronic myelogenous leukemia lymphoblast) whole lysate at 50 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 45 kDa,124 kDa
false
Exposure time: 26s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Low expression : CT26.WT, U-937.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 20944749, 17925379, 19692571, 25239622).
Samples are non-boiled as boiling may cause protein aggregation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (124 kDa) staining at 1/10000 dilution.
Exposure time : Lanes 1-2 : 59 seconds, lanes 3-4 : 26 seconds
All lanes:
Western blot - Anti-Pannexin 1 antibody [EPR28631-135] (<a href='/en-us/products/primary-antibodies/pannexin-1-antibody-epr28631-135-ab325529'>ab325529</a>) at 1/1000 dilution
Lane 1:
Neuro-2a (mouse neuroblastoma neuroblast) whole cell lysate at 20 µg
Lane 2:
CT26.WT (mouse colon fibroblast) whole cell lysate at 20 µg
Lane 3:
PANC-1 (human pancreatic epithelioid carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
U-937 (human histiocytic lymphoma monocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 37-50 kDa,124 kDa
false
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Low expression : SH-SY5Y (PMID : 25883214).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Heparan Sulfate Proteoglycan 2/Perlecan antibody [RM2059] (<a href='/en-us/products/primary-antibodies/heparan-sulfate-proteoglycan-2-perlecan-antibody-rm2059-ab318284'>ab318284</a>) at 1/1000 dilution
Lane 1:
HUVEC (human umbilical vein endothelial cell) whole cell lysate at 20 µg
Lane 2:
SH-SY5Y (human neuroblastoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
EA.hy926 (human somatic cell hybrid endothelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 469 kDa,124 kDa
false
Exposure time: 37s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Negative control : K-562, Hela (PMID : 11855812).
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 11855812, 16737958).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-MUC17 antibody [EPR28482-85] (<a href='/en-us/products/primary-antibodies/muc17-antibody-epr28482-85-ab316971'>ab316971</a>) at 1/1000 dilution
Lane 1:
AsPC-1 (human Pancreas epithelial cell) whole cell lysate at 20 µg
Lane 2:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Lane 3:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 500 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
The lane 4 was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate allows for the detection of proteins in the mid-femtogram range.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
Exposure time : Lanes 1-3 : 92 seconds, lane 4 : 180 seconds
All lanes:
Western blot - Anti-CEP290 antibody [EPR28924-76] (<a href='/en-us/products/primary-antibodies/cep290-antibody-epr28924-76-ab318278'>ab318278</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 2:
HeLa transfected with siRNA specifically targeting CEP290 whole cell lysate at 20 µg
Lane 3:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 40 µg
Lane 4:
Hepa1-6 (mouse hepatoma epithelial cell) whole cell lysate at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 290 kDa,124 kDa
false
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Samples are non-boiled as boiling may cause protein aggregation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-PIEZO2 antibody [EPR27152-48] (<a href='/en-us/products/primary-antibodies/piezo2-antibody-epr27152-48-ab318187'>ab318187</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 2:
HeLa transfected with siRNA specifically targeting PIEZO2 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 320 kDa,124 kDa
false
Exposure time: 92s
- WB
Lab
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
To minimize protein degradation, the fresh lysates were lysed immediately after harvest and then applied to a gel and transfer membrane for Western blotting as soon as possible.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) (1 : 10000) (124KDa).
All lanes:
Western blot - Anti-ATR antibody [EPR30640-130] (<a href='/en-us/products/primary-antibodies/atr-antibody-epr30640-130-ab325605'>ab325605</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 3:
Jurkat (human T cell leukemia T lymphocyte from peripheral blood) whole cell lysate at 20 µg
Lane 4:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 48 µg
Lane 5:
MIA PaCa-2 (human pancreas epithelial cell) whole cell lysate at 48 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 270 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
SON can undergo degradation easily.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 18952841, 27545680).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-SON/DBP5 antibody [EPR28617-69] (<a href='/en-us/products/primary-antibodies/son-dbp5-antibody-epr28617-69-ab317311'>ab317311</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 40 µg
Lane 2:
HeLa transfected with siRNA specifically targeting SON whole cell lysate at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 264 kDa,124 kDa
false
Exposure time: 26s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
In lanes 1-3, the lysates were stored at -80°C prior to Western Blotting. The bands beneath the target band (205 kDa) are likey to be degradation products. In lanes 4-6, the lysates were freshly made and used for Western Blotting immediately to minimize protein degradation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-CDK12 antibody [EPR29009-30] (<a href='/en-us/products/primary-antibodies/cdk12-antibody-epr29009-30-ab317746'>ab317746</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 3:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Lane 4:
HeLa (human cervical adenocarcinoma epithelial cell) whole fresh cell lysate at 20 µg
Lane 5:
293T (human embryonic kidney epithelial cell) whole fresh cell lysate at 20 µg
Lane 6:
K-562 (human chronic myelogenous leukemia lymphoblast) whole fresh cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 205 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-CDK12 antibody [EPR29009-30] (<a href='/en-us/products/primary-antibodies/cdk12-antibody-epr29009-30-ab317746'>ab317746</a>) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 2:
293T transfected with siRNA specifically targeting CDK12 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 205 kDa,124 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
In Western blot, ab316279 was shown to bind specifically to WNK1. Target of interest was observed at 251 kDa in wild-type HAP1 cell lysates (lane 1) with no signal observed at this size in WNK1 knockout cell line (lane 2).
The blot of Lanes 1-3 was developed using a high sensitivity ECL substrate.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
Exposure time : Lanes 1-3 : 125 seconds; Lane 4 : 26 seconds.
All lanes:
Western blot - Anti-WNK1 antibody [EPR28125-60] (<a href='/en-us/products/primary-antibodies/wnk1-antibody-epr28125-60-ab316279'>ab316279</a>) at 1/1000 dilution
Lane 1:
Wild-type HAP1 (human chronic myelogenous leukemia near-haploid cell) whole cell lysate at 20 µg
Lane 2:
WNK1 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 4:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 251 kDa,124 kDa
false
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
Negative control : kidney (PMID : 11855812).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-MUC17 antibody [EPR28482-85] (<a href='/en-us/products/primary-antibodies/muc17-antibody-epr28482-85-ab316971'>ab316971</a>) at 1/1000 dilution
Lane 1:
Human small intestine tissue lysate at 20 µg
Lane 2:
Human kidney tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/2000 dilution
Observed band size: 500 kDa,124 kDa
true
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-Vinculin antibody [EPR8185] - Loading Control (AB129002)
The high-sensitivity ECL substrate allows for the detection of proteins in the mid-femtogram range.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-CEP290 antibody [EPR28924-76] (<a href='/en-us/products/primary-antibodies/cep290-antibody-epr28924-76-ab318278'>ab318278</a>) at 1/1000 dilution
Lane 1:
Human placenta tissue lysate at 50 µg
Lane 2:
Human adrenal gland tissue lysate at 50 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 290 kDa,124 kDa
true
Exposure time: 180s
Related conjugates and formulations (5)
-
Anti-Vinculin antibody [EPR8185] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Vinculin antibody [EPR8185]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Vinculin antibody [EPR8185]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Vinculin antibody [EPR8185]
-
HRP Anti-Vinculin antibody [EPR8185] - Loading Control
Reactivity data
Product details
Anti-Vinculin antibody [EPR8185] (ab129002) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IP and WB.
Anti-Vinculin antibody [EPR8185] (ab129002) was first used in a scientific publication in 2013 and has been cited over 356 times in peer reviewed journals. It's performance in Western Blot in mouse and human samples is trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-Vinculin antibody [EPR8185] (ab129002) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-Vinculin antibody [EPR8185] (ab129002) has been confirmed by Western Blot testing in Vinculin knockout A431 cells.
Anti-Vinculin antibody [EPR8185] (ab129002) has 21 independent reviews from customers.
Vinculin antibodies are often used as loading controls in Western Blot. Anti-Vinculin antibody [EPR8185] has been verified in Western Blot samples and detects a band at 124kDa Molecular weight.
Anti-Vinculin antibody [EPR8185] (ab129002) specifically detects Vinculin (UniProt ID: P18206; Molecular weight: 124kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL, 250 µL and 1 mL).
Conjugation-ready, carrier free format available for antibody clone EPR8185 - ab217171.
Antibody clone EPR8185 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, Alexa Fluor® 555 (ab196454, ab196579, ab206908).
Vinculin is a focal adhesion protein that plays a critical role in cell adhesion, migration and mechanotransduction. In oncology, it influences tumor progression and metastasis by modulating the interactions between cancer cells and the extracellular matrix.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (523)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 16:675 PubMed41053099
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:113449 PubMed41050429
2025
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 10: PubMed40996961
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 21:5586-5608 PubMed40959291
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica et biophysica Sinica : PubMed40931756
2025
Applications
Unspecified application
Species
Unspecified reactive species
Redox biology 86:103839 PubMed40876441
2025
Applications
Unspecified application
Species
Unspecified reactive species
Extracellular vesicle 5: PubMed40642206
2025
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 44:4525-4551 PubMed40624280
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:5980 PubMed40593658
2025
Applications
Unspecified application
Species
Unspecified reactive species
Infectious disease reports 17: PubMed40559196
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com